PATENT CLAIM ANALYSIS

Application Number: 16109224
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "316000"]

Abstract:
The present invention provides N-[1-(1-Cyclohexyl-3,5-dimethyl-1H-pyrazole-4-sulfonyl)-4-phenyl-piperidin-4-ylmethyl]-N-isobutyl-4-{[(piperidin-4-ylmethyl)-amino]-methyl}-benzenesulfonamide and pharmaceutically acceptable salts thereof. These compounds may be useful in the treatment of diseases such as Alzheimer's disease or renal failure. The present invention further relates to methods for the preparation of compounds of Formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising such compounds, and the use of such compounds and/or pharmaceutical compositions in treating certain diseases.

Claim (Index 6):
A method of treatment of a condition comprising administering to a subject a compound of Formula (I) of  claim 1  or a pharmaceutically acceptable salt thereof, wherein the condition is selected from the group consisting of acute and chronic inflammation, skin inflammation, psoriasis, atopic dermatitis, inflammation associated with organ, tissue, or cell transplantation, lung inflammation, asthma, chronic osbtructive pulmonary disease, sepsis, diabetes, diabetic related complications, renal failure, hyperlipidemic atherosclerosis associated with diabetes, neuronal cytotoxicity, restenosis, Down's syndrome, dementia associated with head trauma, amyotrophic lateral sclerosis, multiple sclerosis, amyloidosis, an autoimmune disease, wound healing, periodontal disease, neuropathy, neuronal degeneration, vascular permeability, nephropathy, atherosclerosis, retinopathy, erectile dysfunction, tumor invasion, metastasis, and osteoporosis.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.54237
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14225837', '14049261', '12888660', '14503919', '13772685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6920172314262208
- 35 USC 102 Novelty (BERT): 0.506943127721172
- Combined Prediction Score: 0.673509821055716
- Mean Citation Score: 212.106678
- Max Citation Score: 221.27254
- Similarity Product: 145.17325466902017

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test